Catalyst Pharmaceuticals Company Profile

Aggregated data from the web about Catalyst Pharmaceuticals

Company Name	Catalyst Pharmaceuticals
Website	https://catalystpharma.com
Snippet	Catalyst: A Biopharmaceutical Company Focused on Rare Diseases. LEMS Patients Transitioning to Firdapse®. Information for Prescribers and Patients Available. at 1-833-422-8259 and www.yourcatalystpathways.com. Catalyst’s patient services program, Catalyst Pathways, is only open to enrollment for adult LEMS patients, but its staff is ...
Type	Public company
Revenue	US$ 0 million (2018)[1][2]
Website	www.catalystpharma.com
Industry	Biotechnology
Products	Firdapse® (amifampridine) Tablets 10 mg (commercialized 2019)
Traded as	NASDAQ: CPRXRussell 2000 Component
Key people	Patrick J. McEnany, co-founder, chairman, president and chief executive officer
Headquarters	Coral Gables, Florida, United States
Total assets	US$ 60.5 million (2018)[2]
Total equity	US$ 50.2 million (2018)[2]
Operating income	US$ -35 million (2018)[2]
Number of employees	51 as of March 14, 2019[2]

Catalyst Pharmaceuticals is part of the United States company list

Catalyst Pharmaceuticals is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.